VivoSim Labs (VIVS) Debt Ratio (2011 - 2024)
VivoSim Labs (VIVS) posted Debt Ratio of 0.09 for Q4 2024, up 87290.23% on a QoQ basis from 0.0 in Q4 2016.
Powered by 
Analysis
VivoSim Labs (VIVS) Debt Ratio (2011 - 2024) Analysis & Trends
VivoSim Labs has reported Debt Ratio for 7 years, with the latest figure at 0.09 in Q4 2024.
- On a quarterly basis, Debt Ratio changed N/A year-over-year to 0.09 in Q4 2024; TTM through Dec 2024 was 0.09, a N/A change from a year earlier, with the FY2016 full-year figure at 0.0, down 97.49% from the prior year.
- Debt Ratio was 0.09 for Q4 2024 at VivoSim Labs, up from 0.0 in the prior quarter.
- The five-year high for Debt Ratio was 0.09 in Q4 2024, with the low at 0.09 in Q4 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn | 0.54 |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn | - |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn | 0.21 |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn | 0.35 |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn | 0.39 |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - | 0.30 |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn | - |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn | - |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn | - |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | 0.09 |
| Dec 31, 2016 | 0.00 |
| Sep 30, 2016 | 0.00 |
| Jun 30, 2016 | 0.00 |
| Mar 31, 2016 | 0.00 |
| Dec 31, 2015 | 0.00 |
| Sep 30, 2015 | 0.00 |
| Jun 30, 2015 | 0.00 |
| Mar 31, 2015 | 0.00 |
| Dec 31, 2014 | 0.01 |
| Sep 30, 2014 | 0.00 |
| Jun 30, 2014 | 0.01 |
| Mar 31, 2014 | 0.01 |
| Dec 31, 2013 | 0.02 |
| Sep 30, 2013 | 0.01 |
| Mar 31, 2013 | 0.40 |
| Dec 31, 2012 | 1.23 |
| Dec 31, 2011 | 0.50 |